Luke Joseph Laffin, MD, from the Cleveland Clinic Foundation, answers our questions about his research on the effect of phase 2 cardiac rehabilitation on exercise capacity and outcomes in patients with...
Andres Pineda Maldonado, MD, from the University of Florida, Jacksonville, answers our questions about new therapies for mitral valve disease, the different recommendations for men vs women, and more.
What are the associations between Takotsubo syndrome and cannabis use? In this Q&A, Rupak Desai, MBBS, explains what he and his research team discovered about the relationship and how their results...
James J. Matera, DO, explains the importance of treating hyperkalemia – a common occurrence in patients with chronic kidney disease – in the context of comorbid cardiometabolic disease.
The medical community is uniquely positioned to help combat the spread of medical misinformation. Now that online groups opposed to proven medical interventions are taking aim at statins, here is what...
While SGLT-2 inhibitors are often used in patients with type 2 diabetes, this class of medication can also be used to treat patients with heart failure. In this Q&A, Jennifer Clements, PharmD, discusses a...
Dr Matera discusses common concerns and questions patients with chronic kidney disease ask their physicians, as well as the importance of collaboration between nephrologists and primary care physicians in...
Does consuming caffeine in coffee adversely affect individuals with arrhythmia? Eun-Jeong Kim, MD, explains how her latest findings debunk a long-standing myth and how her research can impact the guidance...
Results of a new study show that women experience gender-specific concerns due to their subcutaneous implantable cardioverter-defibrillators. In this Q&A, Willeke van der Stuijt, MD, highlights those...
The Consumer Technology Association and Heart Rhythm Society have released new guidance on the best practices for consumers who use wearable devices. Lead author Nassir F. Marrouche, MD, from Tulane...
